Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients

Cross-linking of α2-plasmin inhibitor (α2-PI) to fibrin by activated factor XIII (FXIIIa) is essential for the inhibition of fibrinolysis. Little is known about the factors modifying α2-PI incorporation into the fibrin clot and whether the extent of incorporation has clinical consequences. Herein we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagoly, Zsuzsa, Baráth, Barbara, Orbán-Kálmándi, Rita, Szegedi, István, Bogáti, Réka, Sarkady, Ferenc, Csiba, László, Katona, Éva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996613/
https://www.ncbi.nlm.nih.gov/pubmed/33669007
http://dx.doi.org/10.3390/biom11030347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996613/
https://www.ncbi.nlm.nih.gov/pubmed/33669007
http://dx.doi.org/10.3390/biom11030347

Ejemplares similares